Cefabactin 250 mg Tablets for Dogs and Cats
Cefabactin 250 mg Tablets for Dogs and Cats
Authorised
- Cefalexin monohydrate
Product identification
Medicine name:
Cefabactin 250 mg tablets for dogs and cats
Cefabactin 250 mg Tablets for Dogs and Cats
Active substance:
- Cefalexin monohydrate
Target species:
-
Cat
-
Dog
Route of administration:
-
Oral use
-
Oral use
Product details
Active substance and strength:
-
Cefalexin monohydrate262.50milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Cat
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
United Kingdom (Northern Ireland)
Package description:
- Cardboard box of 9 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box of 6 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box of 4 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box of 3 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box of 25 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box of 2 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box of 8 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box of 7 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box of 5 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box of 10 blisters (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box of 1 blister (Aluminium - PVC/PE/PVDC) of 10 tablets
- Cardboard box containing 10 separate cardboard boxes, each containing 1 blister of 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Le Vet. Beheer B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- The Veterinary Medicines Directorate
Authorisation number:
- Vm 41821/4034
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0201/002
Concerned member states:
-
Austria
-
Belgium
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: